Oncology Gold Standard™ consensus statement on counseling patients for molecular testing and personalized cancer care
Purvish M. Parikh, S. S. Hingmire, P. Bhavesh, K. Babu Govind, P. Mehta, A. Verma, S. Bondarde, R. Singh, N. Ghadyalpatil, B. Rangrajan, G. S. Bhattacharya, H. Malhotra, D. C. Doval, A. A. Ranade, P. M. Shah
Director of Precision Oncology, Asian Cancer Institute, Mumbai1Department of Medical Oncology, Deenanath Mangeshkar Hospital, Pune, Maharashtra, 2Department of Medical Oncology, HCG Cancer Hospital, Ahmedabad, Gujarat, 3Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, Karnataka, 4Department of Medical Oncology, Asian Hospital, Faridabad, Haryana, 5Department of Molecular Oncology, Max Hospital, NewDelhi, 6Department of Medical Oncology, Satabdi Hospital, Nashik, Maharashtra, 7Department of Medical Oncology, Artemis Hospital, Gurgaon, NewDelhi, 8Department of Medical Oncology, Yashodha Hospital, Hyderabad, Telangana, 9Department of Medical Oncology, Kovai Cancer Center, Coimbatore, Tamil Nadu, 10Department of Medical Oncology, Fortis Hospital, Kolkata, West Bengal, 11Department of Medicine, SMS Medical College, Jaipur, Rajasthan, 12Department of Medical Oncology and Research, RGCI, NewDelhi, 13Department of Oncology, Avinash Cancer Clinic, Pune, Maharashtra, 14Department of Medical Oncology, Shelby Hospital, Ahmedabad, Gujarat, India,
Advances in molecular oncology technology and their application to personalized cancer care have evolved very rapidly over the past 5 years. At the same time, there are a lot of conflicting and often misleading statements available on the world wide web. This results in confusion and misunderstanding among cancer patients and their well-wishers. We realized that there was an urgent need for developing a consensus document to address this unmet need. Oncology Gold Standard and Molecular Oncology Society, therefore, took up the challenge and formed an expert group that together prepared this consensus statement on counseling patients for molecular testing and personalized cancer care. This is intended to benefit patients, family and friends by improving their broad understanding and equip them to make an informed decision and take active participation in decision-making for their own cancer management - with respect to prevention, diagnosis, treatment, and follow-up of cancer.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.